Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Anxiety, COVID-19, Dyspnoea
Clinical narrative: anxiety issues; lose my taste and smell overnight; lose my taste and smell overnight; a little sore when you press where they check your thyroid; COVID-19; stuffed up nose; couldn't breathe out of it at all, it was just a solid brick; a little bit of wheezing; neck was swollen; red; This spontaneous case was reported by a consumer and describes the occurrence of NASAL CONGESTION (stuffed up nose), DYSPNOEA (couldn't breathe out of it at all, it was just a solid brick), WHEEZING (a little bit of wheezing), SWELLING (neck was swollen) and ERYTHEMA (red) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Thyroid disorder NOS and Bronchitis. Concurrent medical conditions included Anxiety. Concomitant products included IBUPROFEN (EQUATE [IBUPROFEN]) for Allergy.   In April 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In May 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Sep-2021, the patient experienced NASAL CONGESTION (stuffed up nose), DYSPNOEA (couldn't breathe out of it at all, it was just a solid brick), WHEEZING (a little bit of wheezing), SWELLING (neck was swollen), ERYTHEMA (red), NECK PAIN (a little sore when you press where they check your thyroid) and COVID-19 (COVID-19). On 21-Sep-2021, the patient experienced AGEUSIA (lose my taste and smell overnight) and ANOSMIA (lose my taste and smell overnight). On an unknown date, the patient experienced ANXIETY (anxiety issues). The patient was treated with XYLOMETAZOLINE HYDROCHLORIDE (SUDAFED [XYLOMETAZOLINE HYDROCHLORIDE]) in September 2021 for Adverse event, at a dose of UNK dosage form; LEVOTHYROXINE in September 2021 for Adverse event, at a dose of UNK dosage form and HYDROXYZINE in September 2021 for Adverse event, at a dose of UNK dosage form. At the time of the report, NASAL CONGESTION (stuffed up nose), DYSPNOEA (couldn't breathe out of it at all, it was just a solid brick), WHEEZING (a little bit of wheezing), SWELLING (neck was swollen), ERYTHEMA (red), ANXIETY (anxiety issues) and NECK PAIN (a little sore when you press where they check your thyroid) had not resolved, COVID-19 (COVID-19) outcome was unknown and AGEUSIA (lose my taste and smell overnight) and ANOSMIA (lose my taste and smell overnight) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Sep-2021, SARS-CoV-2 test: positive (Positive) Positive.         Concomitant information was not reported.   Most recent FOLLOW-UP information incorporated above includes: On 23-Sep-2021: Follow up received on 23-Sep-21 contains significant information, events not recovered and new events loss of smell and taste reported and they are recovering..; Sender's Comments: This case concerns a  44 year-old, male with a history of bronchitis , thyroid disease and anxiety, who experienced the unexpected events of COVID19, nasal congestion, dyspnoea, wheezing, swelling, erythema and anxiety. The events occurred approximately 5 month after the first dose and 4 month after the most recent dose (second dose) of mRNA-1273 Moderna vaccine (exact date of vaccination has not been provided).   The patient has been exposured to COVID, and tested positive (based on this information and symptoms presented "covid19 was added as event), COVID19 itself added to his medical history of brochitis and anxity could be a potentially confounders The benefit-risk relationship of mRNA-1273 Moderna vaccine in not affected by this report.